In 2017, the Melon Foundation launched Enzyme (MLN), aiming to solve inefficiencies in traditional asset management and democratize access to financial strategies.
As a pioneering on-chain asset management protocol, Enzyme plays a crucial role in the DeFi (Decentralized Finance) sector.
As of 2025, Enzyme has become a key player in decentralized asset management, with an active developer community and growing adoption among DeFi users. This article will delve into its technical architecture, market performance, and future potential.
Enzyme was created by the Melon Foundation in 2017 to address the need for transparent, efficient, and accessible asset management in the blockchain space.
It was born during the early stages of the DeFi revolution, aiming to empower users to create, manage, and invest in on-chain investment strategies without traditional intermediaries.
Enzyme's launch brought new possibilities for both individual investors and fund managers in the crypto space.
With support from the Enzyme community and development team, Enzyme continues to optimize its technology, security, and real-world applications in decentralized asset management.
Enzyme operates on a decentralized network of computers (nodes) spread across the globe, free from control by banks or governments. These nodes collaborate to validate transactions, ensuring system transparency and resistance to attacks, granting users greater autonomy and enhancing network resilience.
Enzyme's blockchain is a public, immutable digital ledger that records every transaction. Transactions are grouped into blocks and linked through cryptographic hashes to form a secure chain. Anyone can view the records, establishing trust without intermediaries. Enzyme leverages Ethereum's blockchain infrastructure while adding its own layer of asset management functionality.
Enzyme utilizes Ethereum's Proof-of-Stake (PoS) consensus mechanism to validate transactions and prevent fraudulent activities like double-spending. Network participants contribute to security by staking ETH and running Ethereum nodes, indirectly supporting Enzyme's operations. Enzyme's innovation lies in its specialized smart contracts for asset management, built on top of Ethereum's secure foundation.
Enzyme uses public-private key cryptography to protect transactions:
This mechanism ensures fund security, while transactions remain pseudonymous. Enzyme also implements additional security features such as access controls and risk management parameters within its vaults.
As of November 20, 2025, Enzyme's circulating supply is 2,988,432.461086299 tokens, which is equal to its total supply. This indicates a fixed supply model.
Enzyme reached its all-time high of $258.26 on January 4, 2018, likely driven by the overall cryptocurrency bull market during that period.
Its lowest price was $1.79, recorded on March 13, 2020, possibly due to the global market crash associated with the COVID-19 pandemic.
These fluctuations reflect market sentiment, adoption trends, and external factors affecting the cryptocurrency space.
Click to view the current MLN market price

Enzyme's ecosystem supports various applications:
Enzyme has established partnerships to enhance its technical capabilities and market influence. These partnerships provide a solid foundation for Enzyme's ecosystem expansion.
Enzyme faces the following challenges:
These issues have sparked discussions within the community and market, driving continuous innovation for Enzyme.
Enzyme's community shows vitality, with metrics such as wallet addresses and daily transaction volumes reflecting its growth. On X, posts and hashtags related to Enzyme (e.g., #EnzymeFinance) frequently gain traction. Factors such as new feature releases and market movements ignite community enthusiasm.
Sentiment on X presents a polarized view:
Recent trends show varying sentiment correlated with market conditions and protocol updates.
X users actively discuss Enzyme's key issues, such as DeFi innovation, asset management strategies, and the future of decentralized finance, highlighting both its transformative potential and the challenges in mainstream adoption.
Enzyme is redefining asset management in the DeFi space through blockchain technology, offering transparency, security, and efficient investment strategies. Its active community, rich resources, and strong market presence make it stand out in the cryptocurrency field. Despite facing challenges such as regulatory uncertainties and technical hurdles, Enzyme's innovative spirit and clear roadmap position it as a significant player in the future of decentralized finance. Whether you're a newcomer or an experienced player, Enzyme is worth watching and participating in.
MLN stands for Melon, a blockchain protocol for on-chain asset management. It enables the creation and management of decentralized hedge funds on Ethereum.
MLN is the token of Enzyme, a decentralized asset management protocol. It's used for governance and fee payments within the Enzyme ecosystem.
MLN is the token of Enzyme Finance, a DeFi protocol on Ethereum for creating tokenized investment products on-chain.
MLN is the token of Enzyme, a decentralized asset management platform. It powers protocol operations and governance in the DeFi ecosystem, ensuring security and integrity.
Share
Content